Personalized Immune Cell Treatment NKCL Classic
- 9th Research Conference held at Kosin University Gospel Hospital in Busan; discussion on adopting ‘multi-omics’ for mechanism elucidation. Continued efforts to review globally advanced technologies for data-driven efficacy validation - NKCL Bio Group proposes integrated immune monitoring system; ...
Kosin University Gospel Hospital (Hospital Director Choi Jong-soon) and NKCL Bio Group (Chairman Shin Dong-hwa) are set to strengthen competitiveness in the field of advanced regenerative medicine through NK cell-based next-generation immune cell therapy research and clinical cooperation. Kosin Unive...
MOU Signing Ceremony Held at Kosin University Gospel Hospital on February 9 (Mon) Joint Advancement in Clinical Research for NK Cell Combination Therapy Targeting Hepatocellular Carcinoma "We Will Accelerate the Realization of Precision Medicine Based on Advanced Regenerative Medical Data" Kosin Univ...
Anticipates Securing Leading Position in Early Diagnosis and Preventive Healthcare Market for Cancer, Dementia, and Other Intractable Diseases Global health tech company Molecular You (MYCo) and NK cell therapy research biotech NKCL Bio Group Co., Ltd. (NKCL) signed a Memorandum of Understanding (MOU...
Spurring Growth as a Domestic Biotech Company Entering the Global Market with NK Cell Automated Incubators NKCL Bio Group (hereinafter referred to as NKCL) announced that it has successfully developed a multi-person (currently up to 16-person) NK cell automated incubator ‘RK-NKTM ACS-II (hereinafter...
Potential for Growth in the Domestic Cell Therapy Market through the Application of Negative Regulation The Ministry of SMEs and Startups announced that on the 21st, it held the "Global Innovation Zone Launch Ceremony" at the Lotte Hotel in Jung-gu, Seoul, with representatives from local governments,...
[ NKCL participates as an anchor company in the Chungbuk Advanced Regenerative Bio Global Innovation Special Zone project ] In establishing a business plan for "Designation of Chungbuk Advanced Regenerative Bio Global Innovation Special Zone" announced last December, on January 19th, hosted by the Ch...
NKCL Bio Group Inc. (Chairman: Shin Dong-hwa) won the Innovation Management Technology Award at the '10th 2023 TV Chosun Management Awards,' announced on the 2nd, marking their consecutive win for the past two years in the technology innovation category. This award is a prestigious recognition given ...
NKCL Bio Group Inc. Receives 'Minister of Science and Technology Award' NKCL Bio Group Inc. (led by Chairman Shin Dong-hwa) declared on the 2nd that it secured the Minister of Science and ICT Award in the technology innovation category at the '10th 2023 TV Chosun Management Awards'. NKCL Bio Group In...
"Chairman Shin Dong-hwa: 'Leading Technology and Market in the Field of NK Cells to Enhance National Competitiveness'" "NKCL Bio Group (NKCL Bio Group Co., Ltd.) has won the 'Minister of Food and Drug Safety Award' in the R&D Management category at the 2023 National Empathy Management Awards. (Ph...
